Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 28Endometrial Neoplasms 9Vaginal Neoplasms 5Ovarian Neoplasms 5Vulvar Neoplasms 3Fallopian Tube Neoplasms 3Esophageal Neoplasms 3Endometrial Clear Cell Adenocarcinoma 3Uterine Neoplasms 2Sarcoma 2Prostatic Neoplasms 2Neoplasms 2Melanoma 2Urinary Bladder Neoplasms 1Stomach Neoplasms 1Sarcoma, Synovial 1Peritoneal Neoplasms 1Pelvic Inflammatory Disease 1Patient Compliance 1Neoplasm Metastasis 1Locally Advanced Cervical Squamous Cell Carcinoma, Not Otherwise Specified 1Locally Advanced Cervical Carcinoma 1Locally Advanced Cervical Adenocarcinoma 1Liposarcoma, Myxoid 1Hyperthermia 1Head and Neck Neoplasms 1HIV Infections 1Endometriosis 1Endometrial Adenocarcinoma 1Diarrhea 1

Interventions

Cisplatin 4sintilimab 2Radiation Dose Hypofractionation 1Radiation 1Platinum 1Irinotecan 1Immunotherapy 1Brachytherapy 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Locally Advanced Cervical Carcinoma × Radiation × Gynecologic × Clear all
NCT06391190 2024-04-30

Concurrent Chemoradiotherapy Followed by PD-1 Inhibitor in Advanced Cervical Cancer

RenJi Hospital

Phase 1/2 Recruiting
20 enrolled
Gynecologic

Locally Advanced Cervical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡